Grufity logo
Grufity logo
PGNY

PGNY - Progyny Inc Stock Price, Fair Value and News

$26.29+0.40 (+1.54%)
Market Closed as of 14 Aug 2026, 04:00 pm ET

56/100

PGNY

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

56/100

PGNY

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

PGNY Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PGNY Price Action

Last 7 days

-6.4%

Last 30 days

-18.7%

Last 90 days

13.1%

Trailing 12 Months

16.6%

PGNY RSI Chart

PGNY Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PGNY Valuation

Market Cap

2.0B

Price/Earnings (Trailing)

25.65

Price/Sales (Trailing)

1.54

EV/EBITDA

14.83

Price/Free Cashflow

11.31

PGNY Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

PGNY Fundamentals

PGNY Revenue

Revenue (TTM)

1.3B

Rev. Growth (Yr)

5.3%

Rev. Growth (Qtr)

6.7%

PGNY Earnings

Earnings (TTM)

78.6M

Earnings Growth (Yr)

63.93%

Earnings Growth (Qtr)

15.76%

PGNY Profitability

EBT Margin

9.14%

Return on Equity

17.35%

Return on Assets

10.98%

Free Cashflow Yield

8.84%

PGNY Investor Care

Buy Backs (1Y)

10.54%

Diluted EPS (TTM)

0.92

PGNY Alerts

  • Big jump in Earnings (Y/Y)
Revenue & Growth

How Progyny Inc generates revenue and covers its expenses, based on the latest reported earnings.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
20261.3B1.3B--
20251.2B1.2B1.3B1.3B
20241.1B1.1B1.1B1.2B
2023873.1M957.5M1.0B1.1B
2022550.7M617.1M700.1M786.9M
2021386.0M450.0M473.4M500.6M
2020263.5M271.9M309.7M344.9M
2019130.3M160.3M193.7M229.7M
201862.8M77.0M91.2M105.4M
2017---48.6M
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About Progyny Inc

PGNY
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
 CEO
 WEBSITEprogyny.com
 SECTORHealthcare
 INDUSTRYHealth Information Services
 EMPLOYEES393

Progyny Inc Frequently Asked Questions

PGNY is the stock ticker symbol of Progyny Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Aug 14 2026, market cap of Progyny Inc is 2.02 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Aug 14 2026, PGNY's PE ratio (Price to Earnings) is 25.65 and Price to Sales (PS) ratio is 1.54. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PGNY PE ratio will change depending on the future growth rate expectations of investors.